To explore whether YAP activation drives the increased expression of MCM7 in liver fibrosis, we treated primary hepatocytes and HepG2 cells with XMU-MP-1, an inhibitor of the Hippo signaling pathway. The gene discussed is MCM7; the disease is Hepatic fibrosis.